Lv21
108 积分 2026-03-17 加入
CD200R signaling in tumor tolerance and inflammation: A tricky balance
3小时前
待确认
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
19天前
已完结
Taming the inflamed heart
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
1个月前
已完结
Resetting autoimmune disease with CAR cell therapies
1个月前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
2个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
2个月前
已完结
Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
2个月前
已完结
Targeted therapy for osteoarthritis: progress and pitfalls
2个月前
已完结
皖公网安备34019202002308
